by GlobeNewsWire | Jun 30, 2016 | Globe Newswire
WALTHAM, Mass., June 30, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO) announced today that it has commenced an underwritten public offering of $300 million of its common stock. In connection with this offering, TESARO plans to grant the underwriters an...
by GlobeNewsWire | Jun 29, 2016 | Globe Newswire
NEWTOWN, Pa., June 29, 2016 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX) (“Onconova” or the “Company”), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced it...
by GlobeNewsWire | Jun 29, 2016 | Globe Newswire
NEW YORK, June 29, 2016 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) announced today that it has commenced an underwritten public offering of $400 million aggregate principal amount of convertible senior notes due 2023 (the notes). RBC...
by GlobeNewsWire | Jun 29, 2016 | Globe Newswire
SEATTLE, June 29, 2016 (GLOBE NEWSWIRE) — Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that the ONT-380 program in advanced HER2+ metastatic breast cancer has received Fast Track designation from the U.S. Food...
by GlobeNewsWire | Jun 29, 2016 | Globe Newswire
CAMBRIDGE, Mass., June 29, 2016 (GLOBE NEWSWIRE) — Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver, a key organ for human metabolism, today announced that...